Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Suspended 1Recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Carcinoma, Renal Cell 17Gastrointestinal Stromal Tumors 10Neoplasms 5Neoplasm Metastasis 4Multiple Myeloma 4Kidney Neoplasms 4Urologic Neoplasms 2Thyroid Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Osteosarcoma 2Meningioma 2Lymphoma, Non-Hodgkin 2Lymphoma 2Kidney Diseases 2Gastrointestinal Neoplasms 2Carcinoma, Hepatocellular 2Carcinoma 2Adenoma, Islet Cell 2Uveal Melanoma 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thymoma 1Stomach Neoplasms 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Rectal Neoplasms 1Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

Magnetic Resonance Spectroscopy 7lutetium Lu 177 dotatate 6Specimen Handling 5Bevacizumab 4gallium Ga 68 dotatate 3abemaciclib 3Radiosurgery 3Proton Therapy 3Nivolumab 3pembrolizumab 2Surveys and Questionnaires 2Sunitinib 2Protons 2Observation 2ONC206 2Ipilimumab 2Hydroxyurea 2Ga(III)-DOTATOC 2Everolimus 2Elasticity Imaging Techniques 2CTLA-4 Antigen 2ribociclib 1regorafenib 1olaparib 1neratinib 1dexamethasone acetate 1dexamethasone 21-phosphate 1capivasertib 1cabozantinib 1brigatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Meningioma × Sunitinib × 1 year × Clear all
NCT06955169 2026-05-22

MOMENTUM-1

RTOG Foundation, Inc.

Phase 2 Suspended
153 enrolled
CNS

Meningioma

NCT06326190 2025-09-16

LUMEN-1

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting
136 enrolled
CNS

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡